Dopamine Agents: all 740 studies that test it
Page 7 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.
- The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory ControlCompletedNCT00660751Not applicable
- Cymbalta for Depression as a Complication of BereavementStatus unknownNCT00658931Phase 4
- Memantine and Intensive Speech-Language Therapy in AphasiaCompletedNCT00640198Phase 4
- Memantine Therapy for Multiple SclerosisTerminatedNCT00638833Phase 2
- Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)CompletedNCT00634556Phase 1
- Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)CompletedNCT00632762Phase 4
- Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)CompletedNCT00630500Phase 2
- Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic IrritabilityCompletedNCT00627250Not applicable
- A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLSCompletedNCT00625547Phase 3
- Memantine - Communication StudyCompletedNCT00624026Phase 3
- Duloxetine for the Treatment of Postpartum DepressionWithdrawnNCT00617045Not applicable
- A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis PainCompletedNCT00609557Phase 4
- Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing OffWithdrawnNCT00601978Phase 4
- Perioperative Treatment of Parkinsonian Patients With Parenteral AmantadineTerminatedNCT00600093Phase 2
- Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic DepressionStatus unknownNCT00596986Not applicable
- Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal DementiaCompletedNCT00594737Phase 3
- Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress DisorderStatus unknownNCT00583193Phase 3
- Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's DiseaseCompletedNCT00558337Phase 2
- Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+CompletedNCT00552682Phase 3
- Duloxetine - Warfarin Pharmacodynamic StudyCompletedNCT00533026Phase 1
- An Open Trial of Duloxetine on Comorbid Major Depression and Chronic HeadacheCompletedNCT00531895Phase 4
- Duloxetine for Perimenopausal DepressionCompletedNCT00517985Phase 4
- Memantine Versus Donepezil in Early Stages of Alzheimer's DiseaseCompletedNCT00505167Phase 4
- Duloxetine Versus Duloxetine Plus Non-Drug Therapy for DepressionCompletedNCT00494377Phase 4
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral TabletsCompletedNCT00491998Phase 1/2
- Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI StudyTerminatedNCT00491348Not applicable
- Duloxetine Versus Paroxetine for Major DepressionCompletedNCT00489775Phase 3
- Duloxetine Versus Placebo for FibromyalgiaCompletedNCT00489073Phase 3
- Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)CompletedNCT00479726Phase 4
- Duloxetine vs Placebo in the Treatment of General AnxietyCompletedNCT00475969Phase 3
- Urge Incontinence Bladder Overactivity StudyCompletedNCT00475696Phase 2
- Duloxetine Stress Urinary Incontinence Efficacy and Safety StudyCompletedNCT00475397Phase 3
- Efficacy and Safety Stress Urinary Incontinence StudyCompletedNCT00475358Phase 3
- A Pilot Clinical Trial Of Memantine for Essential TremorCompletedNCT00439699Phase 4
- Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic NeuropathyCompletedNCT00432393Phase 4
- Open Label Study of Duloxetine for the Treatment of Phantom Limb PainTerminatedNCT00425230Not applicable
- Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With AmantadineCompletedNCT00416962Phase 1
- Evaluation of the Effects of Duloxetine on NorepinephrineCompletedNCT00414323Phase 1
- The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00409721Phase 2
- SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor FluctuationsCompletedNCT00406588Phase 3
- Memantine for Agitation and Aggression in Severe Alzheimer's DiseaseCompletedNCT00401167Phase 4
- A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's DiseaseCompletedNCT00399477Phase 4
- Treatment With Duloxetine for OCD PatientsWithdrawnNCT00399022Not applicable
- A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy VolunteersCompletedNCT00387413Phase 1
- Parkinson's Disease Evaluated by PET and the Effect of MemantineCompletedNCT00375778Not applicable
- Memantine for Agitation in DementiaCompletedNCT00371059Phase 4
- Effects of Pregabalin, Duloxetine & Amitriptyline on Pain & SleepCompletedNCT00370656Phase 2/3
- Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.CompletedNCT00368862Phase 4
- Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00366652Phase 3
- Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)CompletedNCT00353665Phase 2/3
- Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)CompletedNCT00334906Phase 4
- An Open-Label Trial of Memantine in the Treatment of Binge Eating DisorderCompletedNCT00330655Phase 4
- Prophylactic Effect of Memantine in Chronic Tension-Type HeadacheCompletedNCT00315666Phase 3
- Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive ImpairmentStatus unknownNCT00306124Phase 4
- Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's DiseaseCompletedNCT00305903Phase 4
- Namenda to Prevent Post-Operative DeliriumTerminatedNCT00303433Phase 4
- Trial of Memantine for Cognitive Impairment in Multiple SclerosisCompletedNCT00300716Phase 2/3
- Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination TherapyStatus unknownNCT00299923Phase 3
- A Pilot Study Assessing Duloxetine's Efficacy in Atypical DepressionCompletedNCT00296699Phase 4
- Study of Amantadine for Weight Stabilization During Olanzapine TreatmentCompletedNCT00287352Phase 1
- Memantine for Corticosteroid-Induced Mood and Declarative Memory ChangesCompletedNCT00280774Phase 4
- Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve PainCompletedNCT00266643Phase 4
- Treatment of Orthostatic IntoleranceActive, not recruitingNCT00262470Phase 1/2
- A Placebo-Controlled Trial of Memantine for Alcohol DependenceCompletedNCT00246415Phase 2
- To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence SymptomsCompletedNCT00244296Phase 4
- Memantine and Down's SyndromeStatus unknownNCT00240760Not applicable
- Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor TreatmentCompletedNCT00234637Phase 4
- Duloxetine Versus Placebo in the Treatment of FMSCompletedNCT00233025Phase 3
- Treatment of MDEs During the Course of Psychotic Disorders With DuloxetineCompletedNCT00224302Phase 4
- Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
- Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected PatientsCompletedNCT00221624Phase 3
- Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine DependenceCompletedNCT00218075Phase 2
- Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) PatientsCompletedNCT00200538Phase 2
- An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)CompletedNCT00200447Phase 2
- Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:A Randomized Controlled TrialStatus unknownNCT00196703Phase 4
- Switching to Duloxetine From Other AntidepressantsCompletedNCT00191932Phase 4
- A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainCompletedNCT00191919Phase 3
- Duloxetine in the Treatment of Melancholic DepressionCompletedNCT00191685Phase 3
- Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine TrialsCompletedNCT00191594Phase 3
- Open Label Phase III Duloxetine Study for Stress Urinary IncontinenceCompletedNCT00191204Phase 3
- Duloxetine in the Treatment of Stress Urinary Incontinence.CompletedNCT00191087Phase 3
- A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderCompletedNCT00191061Phase 4
- Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary IncontinenceCompletedNCT00190996Phase 3
- Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.CompletedNCT00190905Phase 4
- Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia SyndromeCompletedNCT00190866Phase 3
- Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress IncontinenceCompletedNCT00190853Phase 3
- Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)CompletedNCT00190827Phase 3
- Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.CompletedNCT00190814Phase 3
- To Evaluate the Safety of Duloxetine in Patients With Stress Urinary IncontinenceCompletedNCT00190645Phase 3
- To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary IncontinenceCompletedNCT00190632Phase 3
- Efficacy and Safety of DuloxetineCompletedNCT00190619Phase 3
- Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary IncontinenceCompletedNCT00190606Phase 2
- Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress IncontinenceCompletedNCT00190567Phase 2
- Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical ProstatectomyStatus unknownNCT00188383Phase 1/2
- A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar DegenerationCompletedNCT00187525Phase 4
- Duloxetine for the Treatment of DysthymiaCompletedNCT00185575Not applicable
- Memantine in Systemic Lupus ErythematosusCompletedNCT00181298Not applicable
- Memantine in Patients With Chronic GlaucomaCompletedNCT00168350Phase 3
- Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2CompletedNCT00158132Phase 2
- Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's DiseaseCompletedNCT00153972Phase 4